Clinical Laboratory Tests Market Report 2026

Clinical Laboratory Tests Market Overview

• Clinical Laboratory Tests market size has reached to $150.29 billion in 2025 • Expected to grow to $256.15 billion in 2030 at a compound annual growth rate (CAGR) of 11.2% • Growth Driver: Rising Obesity Levels Fuel Demand For The Market Due To Increasing Need For Metabolic And Risk Factor Monitoring • Market Trend: Advancing Personalized Healthcare Through Direct-To-Consumer Genetic Testing Innovations • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Clinical Laboratory Tests Market?

Clinical laboratory tests refer to medical diagnostic analyses performed on samples such as blood, urine, tissue, or other bodily fluids to detect, diagnose, monitor, or prevent disease. These tests provide critical data to aid physicians in making informed clinical decisions and are commonly used in routine health checkups, disease screening, and treatment monitoring. The main types of clinical laboratory tests are complete blood count, hemoglobin or hematocrit testing, basic metabolic panel testing, blood urea nitrogen creatinine testing, electrolyte testing, HbA1c testing, comprehensive metabolic panel testing, liver panel testing, renal panel testing, and others. A complete blood count (CBC) is a diagnostic test that evaluates the levels of different blood cells to help detect infections, anemia, and other hematological conditions. These services are delivered by hospital-based laboratories, stand-alone laboratories, and clinic-based laboratories. These are commonly applied in areas such as parasitology, virology, hematology, toxicology, immunology or serology, histopathology, and urinalysis and are widely used by central laboratories, hospitals, primary clinics, and others.

What Is The Clinical Laboratory Tests Market Growth Forecast?

The clinical laboratory tests market size is expected to see rapid growth in the next few years. It will grow to $256.15 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to increasing demand for personalized diagnostics, expansion of decentralized and point-of-care testing, growing integration of digital pathology, rising investments in laboratory automation, increasing adoption of predictive diagnostics. Major trends in the forecast period include increasing adoption of automated diagnostic testing platforms, rising demand for high-throughput laboratory testing, growing use of AI-assisted test interpretation, expansion of preventive and screening test programs, enhanced focus on test accuracy and standardization.

Global Clinical Laboratory Tests Market Segmentation

1) By Type: Complete Blood Count, Hemoglobin Or Hematocrit testing, Basic Metabolic Panel Testing, Blood Urea Nitrogen Creatinine Testing, Electrolytes Testing, HbA1c Testing, Comprehensive Metabolic Panel Testing, Liver Panel Testing, Renal Panel Testing, Other Types 2) By Service Provider: Hospital Based Laboratories, Stand-Alone Laboratories, Clinic Based Laboratories 3) By Application: Parasitology, Virology, Hematology, Toxicology, Immunology Or Serology, Histopathology And Urinalysis 4) By End Use: Central laboratories, Primary Clinics, Hospitals, Other End Uses Subsegments: 1) By Complete Blood Count: White Blood Cell (Wbc) Count, Red Blood Cell (Rbc) Count, Hemoglobin (Hgb) 2) By Hemoglobin Or Hematocrit Testing: Hemoglobin Concentration (Hgb), Hematocrit Percentage (Hct), Reticulocyte Count 3) By Basic Metabolic Panel (Bmp) Testing: Glucose, Calcium, Sodium 4) By Blood Urea Nitrogen (Bun) And Creatinine Testing: Bun Level, Serum Creatinine, Bun-To-Creatinine Ratio 5) By Electrolytes Testing: Sodium, Potassium, Chloride 6) By Hba1c Testing: Hba1c (Glycated Hemoglobin), Estimated Average Glucose (Eag) 7) By Comprehensive Metabolic Panel (Cmp) Testing: Alkaline Phosphatase (Alp), Alanine Aminotransferase (Alt), Aspartate Aminotransferase (Ast) 8) By Liver Panel Testing: Total Bilirubin, Direct Bilirubin, Albumin 9) By Renal Panel Testing: Creatinine, Uric Acid, Electrolytes 10) By Other Types: Vitamin And Mineral Panels (Vitamin D, B12, Iron Studies), Infectious Disease Panels, Tumor Markers

What Is The Driver Of The Clinical Laboratory Tests Market?

The rising obesity levels are expected to propel the growth of the clinical laboratory tests market going forward. Obesity levels represent the rate or extent of obesity within a population, usually determined using body mass index criteria. Increasing obesity levels are largely driven by sedentary lifestyles, with reduced physical activity leading to an imbalance between calorie intake and expenditure, resulting in excess fat accumulation. Clinical laboratory tests help monitor and manage obesity levels by identifying underlying health issues, such as hormonal imbalances, metabolic disorders, or nutrient deficiencies, and by tracking obesity-related risk factors such as blood glucose, cholesterol, and liver function to guide personalized treatment plans. For instance, in May 2024, the Office for Health Improvement & Disparities, a UK-based government agency, reported that in England, 64.0% of adults aged 18 and over were estimated to be overweight or living with obesity in 2022–2023. Therefore, the rising obesity levels are driving the growth of the clinical laboratory tests industry.

Key Players In The Global Clinical Laboratory Tests Market

Major companies operating in the clinical laboratory tests market are Roche Diagnostics, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Labcorp, Mayo Clinic Laboratories, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, bioMérieux SA, Bio-Rad Laboratories Inc., QIAGEN NV, Cepheid Inc., OPKO Health Inc., ARUP Laboratories, Thyrocare Technologies Limited, Unilabs Diagnostics AB, Ortho Clinical Diagnostics, Randox Laboratories Ltd, Sysmex Corporation

Global Clinical Laboratory Tests Market Trends and Insights

Major companies operating in the clinical laboratory tests market are focusing on developing advanced solutions, such as consumer-initiated genetic tests, to improve personalized healthcare, boost patient engagement, and broaden access to diagnostic solutions. Consumer-initiated genetic testing is a form of genetic testing that individuals can request directly without needing a physician’s referral, enabling them to uncover insights into their health risks, ancestry, or genetic traits through DNA analysis. For instance, in July 2023, Quest Diagnostics Inc., a US-based medical laboratory company, introduced genetic insights to deliver personalized health risk information based on an individual’s genetic profile. The test examines 36 genes using cutting-edge next-generation sequencing to assess risks for nearly two dozen inheritable conditions, offering tailored, actionable health reports that include physician oversight and complimentary genetic counseling. This saliva-based test is designed to empower individuals to proactively explore their genetic health risks.

What Are Latest Mergers And Acquisitions In The Clinical Laboratory Tests Market?

In December 2024, Wildcat DX LLC, a US-based company focused on providing healthcare services, acquired Navis Clinical Laboratories Inc. for an undisclosed amount. With this acquisition, Wildcat DX, LLC aims to leverage its business network to enhance Navis’s reputation, expand its capabilities, and strengthen growth. This strategic move supports expected synergies and combined annual revenues of around $200 million. Navis Clinical Laboratories Inc. is a US-based clinical laboratory company that offers clinical laboratory tests.

Regional Outlook

North America was the largest region in the clinical laboratory tests market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Clinical Laboratory Tests Market?

The clinical laboratory tests market includes revenues earned by entities by providing services such as routine and specialized lab testing services, and analytical support for disease detection and treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Clinical Laboratory Tests Market Report 2026?

The clinical laboratory tests market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the clinical laboratory tests industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.